The Joint Program Executive Office for Chemical and Biological Defense (Medical Countermeasures Systems) Chemical Defense Pharmaceutical Division is seeking information on the […] More
Chemical weapons pose a serious threat to civilian and warfighter lives, but technology from the U.S. Army Small Business Technology Transfer program […] More
Pine Bluff Arsenal Provides Ammunition, CBRND Readiness for Nation’s Military
Smiths Detection (SDI) has been selected by the U.S. Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and […] More
A snowy, frigid February morning didn’t stop leaders and stakeholders from turning out to view the highly-anticipated Stryker Nuclear, Biological and Chemical […] More
Army Fields New Chemical Detection Technology
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), the military’s lead for development, acquisition, fielding and life-cycle […] More
Mr. Douglas W. Bryce was designated the Joint Program Executive Officer for Chemical and Biological Defense (JPEO-CBD) on 22 October 2015. As the JPEO-CBD, he has materiel acquisition decision authority for the services on chemical and biological defense equipment. He provides acquisition management and professional leadership on complex issues related to joint service chemical and biological defense acquisition programs. He plans, directs, manages, coordinates the JPEO-CBD’s mission and is responsible for the development, acquisition, distribution, and deployment of highly specialized and dynamic joint chemical and biological defense devices, as well as medical diagnostic systems, drugs, and vaccines.
From 2005 to 2015 he was Deputy JPEO-CBD and from 2005 to 2003 he covered the position of Joint Project Manager at the Marine Corps Chemical, Biological, Radiological, Nuclear Defense Equipment (Concurrent Assignment), Marine Corps Systems Command. From 1992 to 1997 he was Product Manager at the Nuclear, Biological, Chemical Defense Equipment, Marine Corps systems Command and from 1988 to 1992 he was the Project Officer of the Nuclear, Biological, Chemical Defense Equipment, Marine Corps Research and Development Command. For over 20 years Mr. Bryce served on Active Duty in the United States Marine Corps.
Dr. Cullin currently serves as FLIR Detection Systems Vice President of Research, Development, and Programs. “Serving as Chair of the CBDAIF is an honor and significant opportunity for me to give back to this community, to work with the JPEO Chem-Bio Defense leadership to help align the commercial sector with the government’s strategic objectives,” stated Dr. Cullin. “I worked for the DOD as a civilian employee for fifteen years, eight within the Chem-Bio Defense Program. I have a great passion to help solve some of our Nation’s biggest challenges, like the WMD threat.”
The Chemical Biological Defense Acquisition Initiatives Forum (CBDAIF) provides a forum for the open exchange of Government and Industry views related to the Department of Defense (DOD) chemical-biological defense mission area. CBDAIF provides an unbiased mechanism for bridging the communication gap between commercial organizations like FLIR by facilitating an open exchange regarding policies, procedures, actions, and issues. It is organized with a Chairman and sector leads from the major commodity areas supporting the Chemical and Biological Defense Program. FLIR’s Dr. David Cullin served as the Detection sector lead in 2014, was nominated by his peers, and approved by the government to serve a three-year term as Chairman of the CBDAIF starting in the Winter of 2015.
The NDIA Annual CBRN Defense Conference and Exhibition is co-sponsored by JPEO-CBD and runs August 2-4, 2016 at Aberdeen Proving Ground. Visit FLIR booth #16 in the exhibit hall and view the full conference agenda here. Dave Cullin will moderate the JPEO-CBD Joint Project Managers Panel starting at 08:45 on August 3rd.